Browsing by Author Galle, Peter R.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 12 to 31 of 38 < previous   next >
PreviewIssue dateOnline publication dateTitleAuthor(s)
healthrelated_quality_of_life-20220805150847806.pdf.jpg20219-Aug-2022Health-related quality of life in patients with autoimmune hepatitisMichel, Maurice; Spinelli, Francesca; Grambihler, Annette; Labenz, Christian; Nagel, Michael; Kaps, Leonard; Huber, Yvonne; Galle, Peter R.; Wörns, Marcus-Alexander; Schattenberg, Jörn M.
hepatic_interleukin1_receptor-20230131122849445.pdf.jpg202213-Feb-2023Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver diseaseGehrke, Nadine; Hofmann, Lea J.; Straub, Beate K.; Rühle, Frank; Waisman, Ari; Galle, Peter R.; Schattenberg, Jörn M.
hepatocyte_bcl3_protects_from-20230210100315764.pdf.jpg202210-Feb-2023Hepatocyte Bcl-3 protects from death-receptor mediated apoptosis and subsequent acute liver failureGehrke, Nadine; Wörns, Marcus A.; Mann, Amrit; Hövelmeyer, Nadine; Waisman, Ari; Straub, Beate K.; Galle, Peter R.; Schattenberg, Jörn M.
58508.pdf.jpg201817-Oct-2018The immune contexture of hepatocellular carcinoma predicts clinical outcomeFoerster, Friedrich; Hess, Moritz; Gerhold-Ay, Aslihan; Marquardt, Jens; Becker, Diana; Galle, Peter R.; Schuppan, Detlef; Binder, Harald; Bockamp, Ernesto
impact_of_thyroid_disorders_o-20221206100750093.pdf.jpg20216-Dec-2022Impact of thyroid disorders on the incidence of non-alcoholic fatty liver disease in GermanyLabenz, Christian; Kostev, Karel; Armandi, Angelo; Galle, Peter R.; Schattenberg, Jörn M.
labenz_christian-incident_demen-20210826121540456.pdf.jpg202126-Aug-2021Incident dementia in elderly patients with nonalcoholic fatty liver disease in GermanyLabenz, Christian; Kostev, Karel; Kaps, Leonard; Galle, Peter R.; Schattenberg, Jörn M.
irritable_bowel_syndrome_and_-20220925163838020.pdf.jpg201317-Oct-2022Irritable bowel syndrome and organic diseases : a comparative analysis of esophageal motilityThomaidis, Thomas; Götz, Martin; Gregor, Sebastian; Hoffman, Arthur; Kouroumalis, Elias; Möhler, Markus; Galle, Peter R.; Schwarting, Andreas; Kiesslich, Ralf
metabolic_dysfunctionassociat-20240123164620740.pdf.jpg202326-Jan-2024Metabolic dysfunction-associated fatty liver disease in people living with HIVMichel, Maurice; Labenz, Christian; Armandi, Angelo; Kaps, Leonard; Kremer, Wolfgang Maximilian; Galle, Peter R.; Grimm, Daniel; Sprinzl, Martin; Schattenberg, Jörn M.
ncadherin_distinguishes_intra-20230112135952723.pdf.jpg202213-Jan-2023N-cadherin distinguishes intrahepatic cholangiocarcinoma from liver metastases of ductal adenocarcinoma of the pancreasGerber, Tiemo S.; Goeppert, Benjamin; Hausen, Anne; Witzel, Hagen R.; Bartsch, Fabian; Schindeldecker, Mario; Gröger, Lisa-Katharina; Ridder, Dirk A.; Cahyadi, Oscar; Esposito, Irene; Gaida, Matthias M.; Schirmacher, Peter; Galle, Peter R.; Lang, Hauke; Roth, Wilfried; Straub, Beate K.
ncadherin__a_diagnostic_marke-20240119091111297.pdf.jpg202419-Jan-2024N-cadherin: a diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomasGerber, Tiemo S.; Ridder, Dirk A.; Goeppert, Benjamin; Brobeil, Alexander; Stenzel, Philipp; Zimmer, Stefanie; Jäkel, Jörg; Metzig, Marie Oliver; Schwab, Roxana; Martin, Steve Z.; Kiss, András; Bergmann, Frank; Schirmacher, Peter; Galle, Peter R.; Lang, Hauke; Roth, Wilfried; Straub, Beate K.
pathogenic_lipidbinding_antip-20220902174134868.pdf.jpg202112-Sep-2022Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19Hollerbach, Anne; Müller-Calleja, Nadine; Pedrosa, Denise; Canisius, Antje; Sprinzl, Martin F.; Falter, Tanja; Rossmann, Heidi; Bodenstein, Marc; Werner, Christian; Sagoschen, Ingo; Münzel, Thomas; Schreiner, Oliver; Sivanathan, Visvakanth; Reuter, Michael; Niermann, Johannes; Galle, Peter R.; Teyton, Luc; Ruf, Wolfram; Lackner, Karl J.
portal_hypertension_in_patien-20240123170726243.pdf.jpg202326-Jan-2024Portal hypertension in patients with hepatocellular carcinoma and immunotherapy : prognostic relevance of CT-morphologic estimatesMüller, Lukas; Gairing, Simon J.; Foerster, Friedrich; Weinmann, Arndt; Mittler, Jens; Stoehr, Fabian; Graafen, Dirk; Düber, Christoph; Galle, Peter R.; Kloeckner, Roman; Hahn, Felix
mähringer-kunz_aline-predicting_sur-20210826101204684.pdf.jpg202026-Aug-2021Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network : a pilot studyMähringer-Kunz, Aline; Wagner, Franziska; Hahn, Felix; Weinmann, Arndt; Brodehl, Sebastian; Schotten, Sebastian; Hinrichs, Jan B.; Düber, Christoph; Galle, Peter R.; Pinto dos Santos, Daniel; Kloeckner, Roman
prevalence_and_clinical_signi-20221201094912961.pdf.jpg20221-Dec-2022Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationMüller, Lukas; Hahn, Felix; Mähringer-Kunz, Aline; Stoehr, Fabian; Gairing, Simon Johannes; Foerster, Friedrich; Weinmann, Arndt; Galle, Peter R.; Mittler, Jens; Pinto dos Santos, Daniel; Pitton, Michael Bernhard; Düber, Christoph; Fehrenbach, Uli; Auer, Timo Alexander; Gebauer, Bernhard; Kloeckner, Roman
ramucirumab_in_patients_with_-20220902173054571.pdf.jpg20217-Sep-2022Ramucirumab in patients with previously treated advanced hepatocellular carcinoma : impact of liver disease aetiologyGalle, Peter R.; Kudo, Masatoshi; Llovet, Josep M.; Finn, Richard S.; Karwal, Mark; Pezet, Denis; Kim, Tae-You; Yang, Tsai-Sheng; Lonardi, Sara; Tomasek, Jiri; Phelip, Jean-Marc; Touchefeu, Yann; Koh, Su-Jin; Stirnimann, Guido; Liang, Kun; Ogburn, Kenyon D.; Wang, Chunxiao; Abada, Paolo; Widau, Ryan C.; Zhu, Andrew X.
review_article__posttipss_hep-20230123094120726.pdf.jpg202223-Jan-2023Review article: post-TIPSS hepatic encephalopathy—current knowledge and future perspectivesGairing, Simon Johannes; Müller, Lukas; Kloeckner, Roman; Galle, Peter R.; Labenz, Christian
risk_factors_for_poorer_healt-20220111115107382.pdf.jpg202114-Jan-2022Risk factors for poorer health literacy in patients with liver cirrhosisKaps, Leonard; Hildebrand, Katharina; Nagel, Michael; Michel, Maurice; Kremer, Wolfgang Maximilian; Hilscher, Max; Galle, Peter R.; Schattenberg, Jörn M.; Wörns, Marcus-Alexander; Labenz, Christian
59893.pdf.jpg202030-Jun-2020Risk prediction in intrahepatic cholangiocarcinoma : direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC cancer staging systemHahn, Felix; Müller, Lukas; Mähringer-Kunz, Aline; Schotten, Sebastian; Düber, Christoph; Hinrichs, Jan B.; Maschke, Sabine K.; Galle, Peter R.; Bartsch, Fabian; Lang, Hauke; Weinmann, Arndt; Kloeckner, Roman
hahn_felix-risk_stratific-20201015161959392.pdf.jpg202016-Oct-2020Risk stratification in advanced biliary tract cancer : validation of the A.L.A.N. scoreMüller, Lukas; Mähringer-Kunz, Aline; Jungmann, Florian; Tanyildizi, Yasemin; Bartsch, Fabian; Czauderna, Carolin; Düber, Christoph; Galle, Peter R.; Weinmann, Arndt; Kloeckner, Roman; Hahn, Felix
michel_maurice-the_role_of_p5-20210723162504858.pdf.jpg20212-Aug-2021The role of p53 dysfunction in colorectal cancer and its implication for therapyMichel, Maurice; Kaps, Leonard; Maderer, Annett; Galle, Peter R.; Moehler, Markus